We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$80B
AUM Growth
+$3.78B
Cap. Flow
+$2.03B
Cap. Flow %
2.54%
Top 10 Hldgs %
13.93%
Holding
3,241
New
178
Increased
2,105
Reduced
536
Closed
137

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$80.9M
2
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$66M
3
MRK icon
Merck
MRK
+$63.3M
4
PG icon
Procter & Gamble
PG
+$58.4M
5
IBM icon
IBM
IBM
+$54.1M

Sector Composition

Rank Sector Weight
1 Healthcare 13.8%
2 Technology 13.16%
3 Financials 12.69%
4 Industrials 10.65%
5 Consumer Staples 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLNE icon
2376
Clean Energy Fuels
CLNE
$381M
$919K ﹤0.01%
264,565
+43,012
+19% +$136K
NVCR icon
2377
NovoCure
NVCR
$2.03B
$918K ﹤0.01%
78,600
+64,700
+465% +$810K
PGNX
2378
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$917K ﹤0.01%
217,100
+114,500
+112% +$553K
SFE
2379
DELISTED
Safeguard Scientifics, Inc.
SFE
$913K ﹤0.01%
73,053
+10,400
+17% +$139K
GCAP
2380
DELISTED
Gain Capital Holdings, Inc.
GCAP
$913K ﹤0.01%
144,329
CMCO icon
2381
Columbus McKinnon
CMCO
$569M
$911K ﹤0.01%
64,329
-1,714
-3% -$26.5K
GERN icon
2382
Geron
GERN
$994M
$910K ﹤0.01%
339,239
+45,839
+16% +$133K
DFRG
2383
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$910K ﹤0.01%
63,481
+924
+1% +$14.4K
HFWA icon
2384
Heritage Financial
HFWA
$1.21B
$909K ﹤0.01%
51,680
TFIN icon
2385
Triumph Financial Inc
TFIN
$1.81B
$905K ﹤0.01%
56,557
RVNC
2386
DELISTED
Revance Therapeutics, Inc.
RVNC
$902K ﹤0.01%
66,263
+1,320
+2% +$23.3K
MNKD icon
2387
MannKind Corp
MNKD
$1.27B
$899K ﹤0.01%
154,941
+1,997
+1% +$12.3K
SREV
2388
DELISTED
ServiceSource International, Inc.
SREV
$898K ﹤0.01%
222,816
-14,384
-6% -$57.1K
BPMC
2389
DELISTED
Blueprint Medicines
BPMC
$888K ﹤0.01%
43,823
+18,320
+72% +$333K
RDEN
2390
DELISTED
ELIZABETH ARDEN INC
RDEN
$888K ﹤0.01%
64,484
-139,295
-68% -$1.39M
FMI
2391
DELISTED
Foundation Medicine, Inc.
FMI
$886K ﹤0.01%
47,447
+672
+1% +$12.1K
FDML
2392
DELISTED
Federal-Mogul Holdings Corporation
FDML
$884K ﹤0.01%
106,355
+1,302
+1% +$11.4K
LEN.B icon
2393
Lennar Class B
LEN.B
$20.5B
$879K ﹤0.01%
25,300
+4,408
+21% +$151K
SENEA icon
2394
Seneca Foods Class A
SENEA
$1.27B
$875K ﹤0.01%
24,147
+378
+2% +$12.5K
VTAE
2395
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$872K ﹤0.01%
80,791
+47,602
+143% +$407K
FNBC
2396
DELISTED
First NBC Bank Holding Company
FNBC
$861K ﹤0.01%
51,273
+1,068
+2% +$20.2K
MTCH icon
2397
Match Group
MTCH
$8.51B
$860K ﹤0.01%
57,045
+1,890
+3% +$24.8K
BBSI icon
2398
Barrett Business Services
BBSI
$760M
$855K ﹤0.01%
82,708
+1,344
+2% +$11.1K
LXU icon
2399
LSB Industries
LXU
$732M
$854K ﹤0.01%
91,803
-85,101
-48% -$849K
XENT
2400
DELISTED
Intersect ENT, Inc
XENT
$851K ﹤0.01%
65,748
+14,340
+28% +$224K

Similar funds

Charles Schwab's Q2 2016 Portfolio in Review

As of Q2 2016, Charles Schwab held 3,241 positions worth $80B, up 5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab's Q2 2016 filing shows 178 new, 2,105 increased, 536 reduced and 137 closed positions. Its largest new stake was S&P Global: 753,915 shares worth $80.9M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $178M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • Charles Schwab's largest Q2 2016 buy was S&P Global: 753,915 shares worth $80.9M.
  • Charles Schwab added most to Merck in Q2 2016, an estimated $63.3M increase.
  • Charles Schwab's biggest Q2 2016 reduction was Computer Sciences, cutting an estimated $61.8M.
  • Charles Schwab fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $178M.
  • Charles Schwab's ten largest holdings make up 14% of its $80B portfolio in Q2 2016.
  • Charles Schwab opened 178 new positions and closed 137 in Q2 2016.
  • Charles Schwab's portfolio value rose 5% quarter-over-quarter to $80B.

Based on Charles Schwab's 13F filing for Q2 2016, filed 15 Aug 2016.